>> 1991:
Rudi Mattmüller and Dieter Mussler establish inomed Medizintechnik in Freiburg. Product development includes the first stimulation probes for direct nerve stimulation.

>> 1992:
Introduction of the Spembly cryosurgery unit targeted at cold therapy for pain. Development of the first high-frequency ablation catheter for cardiac surgery. Development of high-frequency thermo cannulas for pain therapy.
Introduction of the Neurosign 100 Nerve Monitor for ENT and neurosurgery, enabling surgeons to monitor vocal cords, related nerves and facial nerves using accessories developed by inomed.

>> 1993:
Working with the University of Düsseldorf to develop the first NeuroWacs IOM system for spinal monitoring.
Development of thermo probes for functional cranial interventions.

>> 1994 to 1997:
Development of the bipolar needle electrode for recording the Recurrent Laryngeal Nerve and the vocal muscles.
Working with the University Clinic of Würzburg to develop the EWACS IOM system (based on the Neurosign 100).

>> 1997/1998:
First magnetic stimulator sales in France, followed by Germany.
Development of the NS 60 Neurostimulator, followed by the OSIRIS electrical stimulator.
Development of the NeuroExplorer – leading to the ISIS IOM System – designed to deliver a comprehensive approach to neuromonitoring for all departments.

>> 1999 to 2001:
Introduction of neuromonitoring in cardiac and thoracic surgery.
Cooperation with Mison and first sales of the Sonowand Navigation System.
Development of the CLEO Nerve Monitor in cooperation with Magstim.
Development of microelectrodes.
The combined MicroMacroElectrode is developed to enable precise electrophysiological determination of the anatomical target point during functional cranial interventions.

>> 2002 to 2004:
NeMo Neuro Monitor, designed especially for ENT and vascular surgery.
Re-development of the MicroDrive (MD). The MD and related accessories enable the high-precision positioning of up to five electrodes during deep brain stimulation (DBS).
Development of the ISIS MER System. The system’s dual function (recording and stimulation) is designed to optimize target localization by extracellular recording and deep brain stimulation in the same USB based module.

>> 2005 to 2006:
Development of the AEP Module, a miniaturized measurement module with USB port connection to a personal computer intended for recording Acoustic Evoked Potentials.
New adhesive tube electrodes with a larger surface area for recording EMG signals via a standard and user selected ventilation tube (ET).
First sales of the Stockert GmbH Neuro N50 Lesion Generator for use with electrodes and accessories from inomed.

>> 2007 to 2008:
When used with computer tomography images, the inomed planning software (IPS) delivers the optimum access path for clinicians during stereotactic intervention.
USB Amplifier Module: the newest measurement technology for clinical and scientific application.
The OSIRIS Cortical stimulator is designed for direct cortical stimulation during neurosurgery.

>> 2009:
The new C2 NerveMonitor is specifically developed to monitor the laryngeal nerve during thyroid surgery and the facial nerve during ENT surgery.
The V3 tripolar stimulation electrode is developed by inomed to enable continuous monitoring of the Recurrent Laryngeal Nerve via placement on the Vagus Nerve.

>> 2010:
Inauguration of the purpose built headquarters in Emmendingen. The building also includes the affiliated ARKANA seminar center and benefits from the onsite “Kulinarium” restaurant facility open to the public.

The NeuroExplorer software option enables overlay of relevant images from ISIS IOM measuring windows onto the microscope, using the navigation interface on the OPMI Pentero device from Carl Zeiss.

>> 2011: inomed receives the Rudolf-Eberle Innovation Award from the State of Baden-Württemberg. The award is recognition of the invention and development of the ISIS MER portable System.

>> 2011/12: The integration of the Walter Graphtek company into the Neurological Diagnostics division extends the product portfolio alongside the popular Walter EEG systems.

>> 2013: Release of the C3 CryoSystem for pain treatment, targeted at relieving symptoms of pain by locating and freezing peripheral sensory nerves.

>> 2013: inomed is rated as a “TOP 100” company. The award honors inomed for being one of the most innovative medium-sized enterprises in Germany.

>> 2014: Technology for pelvic neuromonitoring is developed, targeted at interventions in the minor pelvis. This includes the resection of colon cancer and other pelvic procedures where nerve preservation is important. pIOM is trademarked and patent registration takes place in Germany.

>> 2015: Laying of the foundation stone for a new wing at the headquarters in Emmendingen.

>> 2016: inomed wins the German Industry Award “Industriepreis Medizintechnik 2016” in the Medical Technology category.

>> 2017:
For inomed the sharing of knowledge and the professional training of customers and employees is very important.
Therefore the online training portal is established in 2017.

In the same year, the webshop for retailers is launched.

>> 2018:
The Polish branch "inomed Polska Sp z o.o." celebrates its 10th anniversary. In addition the C2 software for the C2 NerveMonitor and the C2 Xtend is released. This extends the C2´s range of applications and makes it a practical and efficient all-rounder for a wide range of surgical procedures.

In the same year the inomed Group expands: The subsidiaries "iNCU GmbH" and "ARKANA Forum GmbH" are founded. Thus the inomed Group offers a independent company for professional service in the application of IONM (iNCU GmbH) and for event management and e-learning (ARKANA Forum GmbH).

>> 2019:

"Prize for Patient Safety in Medical Technology" for German patented inomed pIOM technology >> by the German Society for Biomedical Engineering in VDE and the Alliance for Patient Safety

inomed employee and graduate engineer Karin Somerlik-Fuchs was awarded for her outstanding work "Intraoperative Neuromonitoring of the Autonomic Nervous System in the Smaller Pelvis". The work was developed in cooperation with Prof.  Werner Kneist from the University Medical Center Mainz and Prof. Klaus-Peter Hoffmann from the Fraunhofer IBMT, St. Ingbert. This prize honors the pelvic Intraoperative Neuromonitoring (pIONM), which was developed by the research partners in a cooperation lasting more than ten years, starting with basic research and ending with clinical establishment. The resulting Germany-wide patented inomed pIOM technology significantly increases patient safety in highly complex and high-risk interventions on pelvic organs, as it supports the surgeon in preserving nerves during difficult operations.

>> 2020:

The launch of the C2 Xplore opened a new era in IONM. As a further development of the proven C2 NerveMonitor, the C2 Xplore is based on the concept of flexible application possibilities and increased safety in the OR. In addition, the C2 Xplore by inomed impresses with its future-oriented technology and integration into the digital OR.

With its digital features and the new, powerful hardware, the C2 Xplore offers the highest level of usability.

>> 2021
30 years of innovation and partnership: inomed Medizintechnik GmbH celebrates 30th company anniversary
From a start-up to a globally operating medical technology company
Founded on 11 November 1991 by Rudi Mattmüller and Dieter Mussler in Teningen, the two-man business has developed into a strong corporate group over the last three decades. 
inomed Medizintechnik GmbH can look back on a 30-year success story in the development of innovative products in the fields of nerve monitoring, functional neurosurgery and pain treatment.

Press Release >>

>> 2022
One step ahead – After the success of 2013, in 2022 inomed was again awarded the "TOP 100" seal as "one of the most innovative companies in the German medium-sized business sector" by the renowned company compamedia GmbH.

By participating in a multi-stage and independent scientific selection process, which evaluates the innovation management and the innovative success of companies, the TOP 100 jury was convinced of inomed's innovative strength of as well as its innovative process management.